Concepedia

Author

Todd A. Alonzo

University of Southern CaliforniaORCID

Also Known As

A. Alonzo, Todd, Alonzo, Todd A., Gottingen, Henrik Hasle, P. Buchanan, Rhonda E Ries, Stanley Pounds, T A Alonzo, T. A. Alonzo, T. Alonzo

697

Publications

17.2K

Citations

70

H-Index

183

Concepts

All Affiliations

University of Southern CaliforniaChildren's Oncology GroupFred Hutch Cancer CenterChildren's Hospital of PhiladelphiaChildren's Mercy Hospital
TA

About

Todd A. Alonzo is an author at University of Southern California specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

46

3.7K

2

Health Sciences

14

18

617

3

Public Health

13

15

743

4

Engineering

6

6

563

5

Education

1

1

42

Todd A. Alonzo

×

223

Publications

15K

Citations

66

H-Index

YearCitations

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

Hamid Bolouri, Jason E. Farrar, Timothy J. Triche,

Nature Medicine

2017

850

Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi,

Journal of Clinical Oncology

2014

459

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study

Brian V. Balgobind, Susana C. Raimondi, Jochen Harbott,

Blood

2009

444

Clinical implications of FLT3 mutations in pediatric AML

Soheil Meshinchi, Todd A. Alonzo, Derek L. Stirewalt,

Blood

2006

393

The genomic landscape of juvenile myelomonocytic leukemia

Elliot Stieglitz, Amaro Taylor‐Weiner, Tiffany Chang,

Nature Genetics

2015

305

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Michael R. Loken, Todd A. Alonzo, Laura Pardo,

Blood

2012

291

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Beverly J. Lange, Franklin O. Smith, James H. Feusner,

Blood

2007

272

Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor

Michele S. Redell, Marcos J. Ruiz, Todd A. Alonzo,

Blood

2011

259

Using a combination of reference tests to assess the accuracy of a new diagnostic test

Todd A. Alonzo, Margaret S. Pepe

Statistics in Medicine

1999

230

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Alan S. Gamis, Todd A. Alonzo, Robert B. Gerbing,

Blood

2011

228

Page 1